Role of Lipid Peroxidation in ALD: The long-term goal is to determine the pathogenesis of alcoholic liver disease (ALD).
Specific Aims are: 1) To determine the role played by 26s proteasome peptidase inhibition in the protein retention in hepatocytes in experimental ALD in the rat and mouse. 2) To determine the role played by the 20s proteasome peptidase inhibition in the removal of oxidized proteins in hepatocytes in experimental ALD. 3) To determine at the individual liver cell level, using in situ assessment of the phosphorylation-ubiquitin- proteasome pathway, whether the proteasome function is damages in ALD. The studies will focus on correlations made between histopathology, immunohistochemistry and biochemical measurements made on the livers of rats and mouse fed ethanol intragastrically for 2-4 months when significant alterations of liver histology has developed. The basic concept to be tested is that oxidative stress and free radical induced injury initiates a change in protein turnover in the liver cell which shifts the balance between protein synthesis and protein elimination in the liver cell where the net result is protein retention and cell enlargement. Mice deficient in or over expressing CYP2E1 will be studies using the intragastric ethanol feeding model in order to better access the role of CYP2E1 in the pathogenesis of liver cell protein retention in experimental ALD. The mechanism which accounts for the up regulation of CYP2E1 and other proteins retained in the liver cytosol will be identified. In this way the pathogenesis o liver cell enlargement will be determined and the role that this phenomenon plays in ALD will be defined.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA008116-11
Application #
6629565
Study Section
Special Emphasis Panel (ZRG1-SSS-3 (01))
Program Officer
Purohit, Vishnu
Project Start
1990-11-01
Project End
2005-05-31
Budget Start
2003-06-01
Budget End
2004-05-31
Support Year
11
Fiscal Year
2003
Total Cost
$289,821
Indirect Cost
Name
La Biomed Research Institute/ Harbor UCLA Medical Center
Department
Type
DUNS #
069926962
City
Torrance
State
CA
Country
United States
Zip Code
90502
Tippin, Brigette L; Kwong, Alan M; Inadomi, Michael J et al. (2014) Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR. Cancer Med 3:1041-51
Le, Mary D; Enbom, Elena; Traum, Peter K et al. (2013) Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies. Exp Mol Pathol 95:187-91
Khachatoorian, Ronik; Dawson, David; Maloney, Eden M et al. (2013) SAMe treatment prevents the ethanol-induced epigenetic alterations of genes in the Toll-like receptor pathway. Exp Mol Pathol 94:243-6
French, B A; Oliva, J; Bardag-Gorce, F et al. (2012) Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells. Exp Mol Pathol 92:318-26
Oliva, Joan; French, Samuel W; Li, Jun et al. (2012) Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Exp Mol Pathol 93:26-34
Oliva, Joan; Zhong, Jin; Buslon, Virgil S et al. (2012) The effect of SAMe and betaine on Hepa 1-6, C34 and E47 liver cell survival in vitro. Exp Mol Pathol 92:126-30
French, S W; Bardag-Gorce, F; French, B A et al. (2011) The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model. Exp Mol Pathol 91:653-9
French, B A; Oliva, J; Bardag-Gorce, F et al. (2011) The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formation. Exp Mol Pathol 90:252-6
Bardag-Gorce, Fawzia; French, Samuel W (2011) Delta-aminolevulinic dehydratase is a proteasome interacting protein. Exp Mol Pathol 91:485-9
Qing, Xin; French, Babara A; Oliva, Joan et al. (2011) Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms. Exp Mol Pathol 90:51-4

Showing the most recent 10 out of 68 publications